TD Cowen raised the firm’s price target on Genpact (G) to $45 from $40 and keeps a Hold rating on the shares. The firm said its path of F2024 outperformance continued with revenue/EPS beating while a healthy close to the year is targeted too with its 4Q revenue/EPS outlook.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks